New testable hypothesis: "In Huntington’s disease, the temporal evolution of polyglutamine aggregate size distributions (modeled as BV-Wasserstein curves) exhibits a minimal-flux solution consistent with phase-separation condensate ripening, and this minimal flux can be disrupted by MSH3-targeting beta-lactamase inhibitors, measurable via single-cell imaging of aggregate size trajectories."
New testable hypothesis: "In Huntington’s disease, the temporal evolution of polyglutamine aggregate size distributions (modeled as BV-Wasserstein curves) exhibits a minimal-flux solution consistent with phase-separation condensate ripening, and this minimal flux can be disrupted by MSH3-targeting beta-lactamase inhibitors, measurable via single-cell imaging of aggregate size trajectories."
Adversarial Debate Score
34% survival rate under critique
Expert panel critique
Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.
Supporting Research Papers
- Molecular Dynamics Simulations Reveal PolyQ-Length-Dependent Conformational Changes in Huntingtin Exon-1: Implications for Environmental Co-Solvent Modulation of Aggregation-Prone States
Huntington's disease (HD) is caused by CAG-repeat expansion in HTT, which lengthens the polyglutamine (polyQ) tract in huntingtin (HTT) and promotes misfolding and aggregation. While polyQ-length-depe...
- Deciphering the Inhibitory Mechanism of ALS-Associated N352S and S352p Variants against TDP-43 Aggregation and Its Destabilization Effect on TDP-43 Protofibrils.
Amyotrophic lateral sclerosis (ALS) is closely related to ubiquitin-positive inclusions formed by transactive response deoxyribonucleic acid (DNA) binding protein of 43 kDa (TDP-43). Previous experime...
- Mapping high resolution, multidimensional phase diagrams of physiological protein condensates
Biomolecular condensates are membraneless compartments, crucial for organising and regulating diverse cellular processes. Current approaches to study condensate biology either use simplified recombina...
- Rational Design of TDP-43 Derived α-Helical Peptide Inhibitors: An In Silico Strategy to Prevent TDP-43 Aggregation in Neurodegenerative Disorders
TDP-43, an essential RNA/DNA-binding protein, is central to the pathology of neurodegenerative diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia. Pathological mislocalization...
- Dissecting the Effect of ALS Mutation G335D on the Early Aggregation of the TDP-43 Amyloidogenic Core Peptide: Helix-to-β-Sheet Transition and Conformational Shift
The aggregation of TAR DNA-binding protein of 43 kDa (TDP-43) into fibrillary deposits is associated with amyotrophic lateral sclerosis (ALS). The 311-360 fragment of TDP-43 (TDP-43311-360), the amylo...
Formal Verification
Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.